Psychotropic medication use and risk of epithelial ovarian cancer

Keyphrases

• Epithelial Ovarian Cancer 100%
• Confidence Interval 100%
• Odds Ratio 100%
• Medication Risk 100%
• Psychotropic Drug Use 100%
• Ovarian Cancer 60%
• Antidepressants 40%
• Increasing Risk 40%
• Gonadotropin Secretion 40%
• Antipsychotics 20%
• Etiology 20%
• Medication Use 20%
• Newly Diagnosed Ovarian Cancer 20%
• Massachusetts 20%
• Clinical Practice 20%
• New Hampshire 20%
• Benzodiazepines 20%
• Sedative 20%
• First Use 20%
• Cancer Pathogenesis 20%
• Ovarian Cancer Risk 20%
• Length of Use 20%
• Specific Action 20%
• Amphetamine 20%
• Self-reported Use 20%
• Adrenergic Receptors 20%
• Barbiturates 20%
• Random Digit Dialing 20%
• Anticonvulsant 20%
• Tranquilizers 20%
• Serotoninergic Agents 20%
• Age of First Use 20%
• Hypothalamic-pituitary-ovarian Axis 20%
• Borderline Epithelial Ovarian Tumor 20%
• Ovarian Stimulation 20%
• Dopaminergic Mechanisms 20%
• GABAergic Pathway 20%
• Malignant Epithelial Ovarian Tumor 20%
• Precinct 20%
• Fold Increase 20%

Medicine and Dentistry

• Krukenberg Tumor 100%
• Odds Ratio 100%
• Ovarian Cancer 80%
• Case-Control Study 40%
• Gonadotropin Release 40%
• Antidepressant 40%
• Prematurity 20%
• Cancer Risk 20%
• Ovarian Tumor 20%
• Sedative Agent 20%
• Anticonvulsant 20%
• Etiology of Ovarian Cancer 20%
• Adrenergic Receptor 20%
• Amphetamine Derivative 20%
• Anxiolytic 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Ovary Carcinoma 100%
• Psychotropic Agent 100%
• Ovary Cancer 83%
• Antidepressant 33%
• Case-Control Study 33%
• Gonadotropin 33%
• Ovary Tumor 16%
• Dopamine Receptor Stimulating Agent 16%
• Anticonvulsive Agent 16%
• Prematurity 16%
• Adrenergic Receptor 16%
• Amphetamine Derivative 16%
• Anxiolytic 16%